| ［1］ |
王海燕.肾脏病临床概览［M］.北京：北京大学医学出版社，2014：258.
|
| ［2］ |
Mary KC.Advances in understanding the role of typeⅠinterferons in SLE［J］.Curr Opin Rheumatol，2014，26（5）：467-474.
|
| ［3］ |
Nathan C.Neutrophils and immunity：challenges and opportunities［J］.Nat Rev Immunol，2006，6（3）：173-182.
|
| ［4］ |
Garcia-Romo GS，Caielli S，Vega B，et al.Netting neutrophils are major inducers of typeⅠIFN production in pediatric sysremic lupus erythematosus［J］.Sci Transl Med，2011，3 （73）：7320.
|
| ［5］ |
Gertnel J，Annette JT，Chrisna D，et al.Pneumolysin activates neutrophil extracellular trap formation［J］.Clin Exp Immunol，2016，28（10）：1276.
|
| ［6］ |
Lande R，Ganguly D，Facchinetti V，et al.Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA peptide complexes in systemic lupus erythematosus［J］.Sci Transl Med，2011，3（73）：19.
|
| ［7］ |
Umeharu O，Takuma S，Hiromi T，et al.Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9［J］.Nature，2015，520（7549）：702-705.
|
| ［8］ |
Wang HT，Li T，Chen S，et al.Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin［J］. Arthrit Rheum，2015，67（12）：3190-3200.
|
| ［9］ |
Jiang W，Lederman MM，Harding CV，et al.TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function［J］.Eur J Immunol，2007，37（8）：2205-2213.
|
| ［10］ |
Cigini A，Pileri PV，Faedda R，et al.Interleukin 1，interleukin 6，interleukin 10 and tumor necrosis factor α in active and quiescent systemic lupus erythematosus［J］.J Investig Med，2014，62（5）：825-829.
|
| ［11］ |
Zorro S，Arias M，Riaño F，et al.Response to CpG-ODN by B cells from patients with systemic lupus erythematosus correlates with disease activity［J］.Lupus，2009，18（8）：718-726.
|
| ［12］ |
Hochberg MC.Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus［J］.Arthritis Rheum，1997，40（9）：1725.
|
| ［13］ |
陆再英，钟南山.内科学［M］.7版.北京：人民卫生出版社，2010：549，860-864.
|
| ［14］ |
Dwivedi N，Upadhyay J，Neeli I，et al.Felty′s syndrome autoantibodies bind to deiminated histones and neutrophil extracelluar chromatin traps［J］.Arthritis Rheum，2012，64（4）：982-992.
|
| ［15］ |
Elkon KB，Santer DM.Complement，interferon and lupus［J］. Curr Opin Immunol，2012，24（6）：665-670.
|
| ［16］ |
Rönnblom L，Alm GV.A pivotal role for the natural interferon-α producing cells（plasmacytoid dendritic cells）in the pathogenesis of lupus［J］.J Exp Med，2001，194（12）：59-63.
|
| ［17］ |
Zheng C，Chen J，Wu X，et al.CpG-ODN activation of TLR9 signaling pathways and NF-κB in STZ-induced diabetic rats［J］.Zhonghua Yi Xue Za Zhi，2014，94（42）：3334-3337.
|
| ［18］ |
Sumiko I，Maeyama J，Fumiko S.CpG oligodeoxynucleotides as mucosal adjuvants［J］.Hum Vaccines Immunotherap，2015，11（3）：755-760.
|
| ［19］ |
Soner Y，Alpdundar E，Bilgi G，et al.Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG［J］.Eur J Immunol，2015，45（4）：1170-1179.
|
| ［20］ |
Means TK，Latz E，Hayashi F，et al.Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9［J］.J Clin Invest，2005，115（2）：407-417.
|
